Stock screenerAll disclosures →
EDGAR →
TNXP
Conviction 38HealthcareScan · Mon, Aug 10, 2026TNXP$12.59+4.66%
ResistanceSupportVol 14Insider buyVol MA14 493.97K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price12.59
Change+4.66%
Gap-4.41%
Rel volume3.08×
Avg volume506.01K
Avg $ vol5.63M
SMA 2011.00
SMA 5011.63
SMA 20014.58
Price vs 50+8.29%
Price vs 200-13.66%
MA stackmixed
50/200 cross—
Supertrendup · 9.84
RSI (14)60
MACD hist0.27
MACD crossbull · 4d
Stoch %K / %D72 / 82
ADX (14)17
+DI / −DI32 / 13
RSI divergence—
MACD divergence—
ATR %+7.20%
ADR %7.67%
52w high61.57
52w low9.51
From 52w high-79.55%
Above 52w low+32.39%
New 52w highNo
SqueezeOff
Bollinger width31.30%
%B0.96
Donchian pos72.34%
Donchian high13.81
Donchian low9.40
AVWAP (52w high)21.62
vs AVWAP high-41.78%
AVWAP (52w low)11.49
vs AVWAP low+9.56%
OBV trendUp
Chaikin MF (20)-0.03
Today vs 20d3.08×
Avg vol (14d)493.97K
Avg vol (20d)506.01K
Avg $ vol (20d)5.63M
Market cap215.93M
RS 3m (vs SPY)-17.37%
RS 6m (vs SPY)-33.65%
RS line new highNo
Trend template2/8
Technical rank42.3
1 week+18.05%
1 month+0.48%
3 months-10.65%
6 months-22.95%
1 year-73.17%
YTD-23.93%
P/E-1.74
P/B0.97
P/S16.47
P/FCF-2.09
EPS-14.57
Div yield—
ROE-55.79%
ROA-48.81%
Debt/Eq0.03
Current6.61
EV/EBITDA-0.38
Gross margin—
Net margin-946.22%
Rev growth29.85%
EPS growth4.63%
Price target38.00
Target upside201.83%
Analyst ratingBuy
Institutional39.90%
Ent. value47.19M
Revenue13.54M
Net income-40.55M
Gross profit—
Free cash flow-103.21M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out15.94M
Employees142
ListedFri, Feb 13, 2009
Free float15.62M
Float %98.0%
Short interest3.58M
Days to cover7.2d
Short volume46.8%
Squeeze score85 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$2.93 vs −$2.38
Last surprise-23.1% miss
Setup gradeD
Conviction38 / 100
Pattern quality—
Tech rank42.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance13.38
Support9.61
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in TNXP
No recent disclosed trades by Congress in TNXP. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in TNXP · 9 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
SAENGER BRADLEY Chief Financial Officer · Common Stock, $0.001 par value · 2026-06-30 | Acquire | 1.45K | $16K | 2026-06-30 | 2026-07-09 |
LEDERMAN SETH Chief Executive Officer · Common Stock, $0.001 par value · 2026-06-09 | Other | — | — | 2026-06-09 | 2026-06-09 |
LEDERMAN SETH Chief Executive Officer · Common Stock, $0.001 par value · 2026-06-09 | Buy | 5K | $59K | 2026-06-09 | 2026-06-09 |
Stillwell Richard Newcomb Director · Common Stock, $0.001 par value · 2026-06-08 | Buy | 5K | $58K | 2026-06-08 | 2026-06-09 |
Stillwell Richard Newcomb Director · Stock Option · 2026-05-12 | Grant | 22.7K | $0 | 2026-05-12 | 2026-05-14 |
BAGGER RICHARD H Director · Stock Option · 2026-05-12 | Grant | 22.7K | $0 | 2026-05-12 | 2026-05-14 |
Hunter James Randolph Jr Director · Stock Option · 2026-05-12 | Grant | 22.7K | $0 | 2026-05-12 | 2026-05-14 |
Treco James Director · Stock Option · 2026-05-12 | Grant | 22.7K | $0 | 2026-05-12 | 2026-05-14 |
GRANGE DAVID L Director · Stock Option · 2026-05-12 | Grant | 22.7K | $0 | 2026-05-12 | 2026-05-14 |
Bell Margaret Smith Director · Stock Option · 2026-05-12 | Grant | 22.7K | $0 | 2026-05-12 | 2026-05-14 |
SEC filings
EDGAR filings in TNXP · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.